David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 28,891 shares at $40.30 ($1.2M) on 2021-05-05, disclosed to the SEC on 2021-05-10.
Open-market sale of $1.2M PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.36 | 3,415 | $134K | 11.6% |
| 2 | $39.36 | 3,415 | $134K | 11.6% |
| 3 | $40.30 | 10,476 | $422K | 36.4% |
| 4 | $40.30 | 10,476 | $422K | 36.4% |
| 5 | $41.07 | 1,109 | $46K | 3.9% |
| Total | $40.11 avg | 28,891 |
| $1.2M |
| 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |